论文部分内容阅读
目的：评价新辅助化疗同时化疗及高剂量放疗（新辅助治疗方案）治疗食管鳞癌的疗效。方法：选择４５例肿瘤病期为Ｔ１～４Ｎ０～１Ｍ０的食管鳞癌患者（男３４例、女１１例），中位年龄６１岁（３８～７７岁）。入组标准：≥１８岁，ＥＣＯＧ状态０～２级，血清肌酐≤１．５ｍ?
Objective: To evaluate the efficacy of concurrent neoadjuvant chemotherapy and high-dose radiotherapy (neoadjuvant treatment) for the treatment of esophageal squamous cell carcinoma. Methods: Forty-five patients with esophageal squamous cell carcinoma (34 males and 11 females) with T1～4N0～1M0 tumors were selected. The median age was 61 years (38-77 years old). Eligibility criteria: ≥ 18 years old, ECOG status 0-2, serum creatinine ≤ 1.5m?